These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10979930

  • 1. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
    Choo S, Zhang Q, Seymour L, Akhtar S, Finn A.
    J Infect Dis; 2000 Oct; 182(4):1260-3. PubMed ID: 10979930
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [Abstract] [Full Text] [Related]

  • 3. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
    Bermal N, Szenborn L, Chrobot A, Alberto E, Lommel P, Gatchalian S, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
    [Abstract] [Full Text] [Related]

  • 4. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
    Nurkka A, Ahman H, Korkeila M, Jäntti V, Käyhty H, Eskola J.
    Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
    [Abstract] [Full Text] [Related]

  • 5. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
    Vanderkooi OG, Scheifele DW, Girgenti D, Halperin SA, Patterson SD, Gruber WC, Emini EA, Scott DA, Kellner JD, Canadian PCV13 Study Group.
    Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
    [Abstract] [Full Text] [Related]

  • 6. Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
    Nurkka A, Lahdenkari M, Palmu AA, Käyhty H, FinOM Study Group.
    BMC Infect Dis; 2005 May 27; 5():41. PubMed ID: 15921511
    [Abstract] [Full Text] [Related]

  • 7. Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.
    Wysocki J, Tansey S, Brachet E, Baker S, Gruber W, Giardina P, Arora A.
    Vaccine; 2010 Nov 16; 28(49):7779-86. PubMed ID: 20883736
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years.
    Miernyk KM, Parkinson AJ, Rudolph KM, Petersen KM, Bulkow LR, Greenberg DP, Ward JI, Brenneman G, Reid R, Santosham M.
    Clin Infect Dis; 2000 Jul 16; 31(1):34-41. PubMed ID: 10913393
    [Abstract] [Full Text] [Related]

  • 9. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
    de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.
    Clin Infect Dis; 2008 Apr 01; 46(7):1015-23. PubMed ID: 18444818
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 01; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [Abstract] [Full Text] [Related]

  • 11. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.
    Clin Infect Dis; 2007 May 01; 44(9):1173-9. PubMed ID: 17407035
    [Abstract] [Full Text] [Related]

  • 12. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D, Veenhoven RH, Ramdin R, Luijendijk IH, Rijkers GT, Sanders EA, de Groot R, Hermans PW.
    Vaccine; 2005 Apr 08; 23(20):2607-13. PubMed ID: 15780443
    [Abstract] [Full Text] [Related]

  • 13. Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
    Nurkka A, Lahdenkari M, Palmu A, Käyhty H, FinOM Study Group.
    Vaccine; 2004 Dec 02; 23(3):298-304. PubMed ID: 15530671
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
    Lin PL, Michaels MG, Green M, Mazariegos GV, Webber SA, Lawrence KS, Iurlano K, Greenberg DP.
    Pediatrics; 2005 Jul 02; 116(1):160-7. PubMed ID: 15995047
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
    Goldblatt D, Southern J, Ashton L, Richmond P, Burbidge P, Tasevska J, Crowley-Luke A, Andrews N, Morris R, Borrow R, Cartwright K, Miller E.
    Pediatr Infect Dis J; 2006 Apr 02; 25(4):312-9. PubMed ID: 16567982
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
    Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA, PCV13 Infant Study Group.
    Pediatrics; 2010 May 02; 125(5):866-75. PubMed ID: 20435707
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R, Kayhty H, Wuorimaa T, Yaich M, Bailleux F, Zamir O, Eskola J.
    Pediatr Infect Dis J; 2004 Feb 02; 23(2):91-8. PubMed ID: 14872172
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P, Benkerrou M, de Montalembert M, Lesprit E, Abadie I, Bernaudin F, Doit C, Bingen E, Tetelboum R, Bonnet E.
    Pediatr Infect Dis J; 2007 Dec 02; 26(12):1105-9. PubMed ID: 18043446
    [Abstract] [Full Text] [Related]

  • 19. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.
    J Infect Dis; 1999 May 02; 179(5):1152-6. PubMed ID: 10191217
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 02; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.